Antioxidant Potential of a Non-Heme Iron Complex: Mitigating H₂O₂-Induced Cellular Damage.

Authors

Magy A Mekhail, David M Freire, Cameron Bowers, Grant Elam, Nora Del Bosque, Hannah K Pyle, Sarah K Dunn, Spencer Lanyon, Timothy J Hubin, Giridhar Akkaraju, Kayla N Green

Published in

Inorganic chemistry. Jun 16, 2026. Epub Jun 16, 2026.

Abstract

Iron complexes with antioxidant activity have garnered significant interest for both general and medical applications, yet few studies have yielded functional nonheme iron-based mimics for H₂O₂ mitigation in aqueous environments. Here, we investigate water-soluble nonheme iron complexes derived from 12-membered pyridinophanes (^CF₃PyN₃, PyN₃, ^NMe₂PyN₃, and Py₂N₂) to evaluate the impact of ligand scaffolds on H₂O₂ decomposition activity both in vitro and in a cellular model. Speciation and kinetic analyses reveal that both electronic and geometric modulation of the macrocyclic ligand framework govern H₂O₂ disproportionation activity. Electron-donating substituents accelerate turnover but reduce stability, while electron-withdrawing groups enhance robustness at the expense of rate. The unsubstituted Fe(PyN₃)³⁺ complex achieves the optimal balance, exhibiting the highest catalytic efficiency (k = 1.45 M^-1 s^-1) and turnover number (TON = 33) under physiological conditions. Crystallographic characterization of the Fe(Py₂N₂)³⁺ complex, reported here for the first time, revealed a μ-oxo-bridged dimeric structure that rationalizes its diminished reactivity. Collectively, these findings define key design parameters for constructing stable, Fenton-resistant nonheme iron catalysts. Extending this chemistry to a biological context, Fe(PyN₃)³⁺ was shown to mitigate H₂O₂-induced oxidative stress in HeLa cells by catalytically reducing intracellular ROS levels and improving cell viability. The integration of molecular, mechanistic, and cellular data demonstrates that well-defined iron-pyridinophane frameworks can translate homogeneous catalytic behavior into complex biological systems, offering a foundation for the design of therapeutic antioxidant catalysts.

PMID:
42299721
Bibliographic data and abstract were imported from PubMed on 16 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.